Molecular profiling of clinical tissues specimens: feasibility and applications

scientific article

Molecular profiling of clinical tissues specimens: feasibility and applications is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S1525-1578(10)60617-4
P932PMC publication ID1906897
P698PubMed publication ID11272889

P2093author name stringG Lennon
M R Brown
R D Klausner
R L Strausberg
L A Liotta
M B Soares
M R Emmert-Buck
M F Bonaldo
D K Ornstein
G D Schuler
M A Marra
W M Linehan
K H Buetow
D G Bostwick
R H Waterston
P H Duray
P J Munson
R F Bonner
D B Krizman
K S Katz
A E Lash
V V Prabhu
L Grouse
K A Cole
C D Vocke
R F Chuaqui
J W Gillespie
C M Tolstoshev
C R Englert
L W Hillier
S Greenhut
V Kuznetzov
C Prang
P2860cites workHigh expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostateQ24684793
Serial analysis of gene expressionQ27860777
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancerQ27860985
Quantitative monitoring of gene expression patterns with a complementary DNA microarrayQ27861102
Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lungQ28253904
3,400 new expressed sequence tags identify diversity of transcripts in human brainQ28261851
The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expressionQ28277156
Laser capture microdissectionQ28293867
Generation and analysis of 280,000 human expressed sequence tagsQ28294585
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide searchQ28296089
Positional cloning of the gene for multiple endocrine neoplasia-type 1Q28307577
Exploring the new world of the genome with DNA microarraysQ29616559
High density synthetic oligonucleotide arraysQ29616560
Use of a cDNA microarray to analyse gene expression patterns in human cancerQ29618814
Gene expression profiles in normal and cancer cellsQ29619943
Molecular advances in prostate cancer.Q30470232
Reliable identification of large numbers of candidate SNPs from public EST dataQ30559720
The mammalian gene collectionQ30649748
Development of a prostate cDNA microarray and statistical gene expression analysis packageQ30872500
Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysisQ31920335
Gene expression profiles of laser-captured adjacent neuronal subtypesQ31936624
An improved method for construction of directionally cloned cDNA libraries from microdissected cellsQ31956611
Identification of expressed genes by laser-mediated manipulation of single cellsQ32039841
Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysisQ32158642
Laser capture microdissection: molecular analysis of tissueQ32165447
Pattern recognition and arrays: the times are a-changingQ33611023
Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinomaQ34435214
Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples.Q35834245
Multiplexed biochemical assays with biological chipsQ36696420
Review of allelic loss and gain in prostate cancerQ36831730
Construction of a representative cDNA library from prostatic intraepithelial neoplasiaQ36838328
A physical map of 30,000 human genesQ38476708
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasiaQ41674939
Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors.Q42825366
Loss of chromosome arm 8p loci in prostate cancer: Mapping by quantitative allelic imbalanceQ46073624
Array of hopeQ47606760
New goals for the U.S. Human Genome Project: 1998-2003.Q48014748
cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer.Q48026953
Shotgun sequencing of the human genome.Q52240857
A catalog of cancer genes at the click of a mouse.Q55067048
Evidence for a prostate cancer susceptibility locus on the X chromosome.Q57274826
Entering the postgenome eraQ71768324
Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancerQ72789870
Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) geneQ73148757
New opportunities for uncovering the molecular basis of cancerQ73317767
Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysisQ73352853
The cancer genome anatomy project: building an annotated gene indexQ73480702
11q13 allelotype analysis in 27 northern American MEN1 kindreds identifies two distinct founder chromosomesQ74487545
Drug target validation and identification of secondary drug target effects using DNA microarraysQ77534975
The genetics of cancer--a 3D modelQ77895897
P433issue2
P304page(s)60-66
P577publication date2000-05-01
P1433published inThe Journal of Molecular DiagnosticsQ7743603
P1476titleMolecular profiling of clinical tissues specimens: feasibility and applications
P478volume2

Reverse relations

cites work (P2860)
Q45777510A comparative analysis of two tissue procurement approaches for the genomic profiling of clinical colorectal cancer samples
Q38430982An exfoliation and enrichment strategy results in improved transcriptional profiles when compared to matched formalin fixed samples.
Q33418010Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry
Q31125912Combined laser capture microdissection and serial analysis of gene expression from human tissue samples
Q31087940DNA microarrays in prostate cancer.
Q78552299Differential expression profiling of head and neck squamous carcinoma: significance in their phenotypic and biological classification
Q53401188Evaluation of Maxwell® 16 for automated DNA extraction from whole blood and formalin-fixed paraffin embedded (FFPE) tissue.
Q35869324Expression profiling of human tumors: the end of surgical pathology?
Q34022119Functional genomics and expression profiling: be there or be square
Q38435255Genome-controlled reverse transcriptase-polymerase chain reaction for targeted gene-expression analysis.
Q78511667Genomics and proteomics: application of novel technology to early detection and prevention of cancer
Q46750730Grating-coupled surface plasmon resonance: a cell and protein microarray platform
Q28211229Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers
Q33942107Influence of hypoxia induced by minimally invasive prostatectomy on gene expression: implications for biomarker analysis
Q30847490Infrared micro-spectral imaging: distinction of tissue types in axillary lymph node histology
Q47796061Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research
Q28250373Laser capture microdissection technology
Q60673340Laser-capture microdissection
Q33218898Manual exfoliation of fresh tissue obviates the need for frozen sections for molecular profiling
Q36177378Microarrays in veterinary diagnostics
Q33317096Preservation of biomolecules in breast cancer tissue by a formalin-free histology system
Q33455428Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples
Q31148835Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers
Q30724646The Cancer Genome Anatomy Project: new resources for reading the molecular signatures of cancer
Q34497407The future of colon cancer prevention
Q36573836Tissue detection of biomolecular predictors in breast cancer
Q36038504Tissue imprint for molecular mapping of deep surgical margins in patients with head and neck squamous cell carcinoma
Q57305675Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsule
Q33904277Why is it crucial to reintegrate pathology into cancer research?